{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer stem cells", "carcinogenesis", "cervical cancer", "chemoresistance", "endometrial cancer", "gynecologic cancer", "molecular mechanism", "ovarian cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35250573", "DateRevised": {"Year": "2022", "Month": "03", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "16"}], "Language": ["eng"], "ELocationID": ["823572", "10.3389/fphar.2022.823572"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.", "Pagination": {"StartPage": "823572", "MedlinePgn": "823572"}, "Abstract": {"AbstractText": ["Gynecologic cancer is one of the main causes of death in women. In this type of cancer, several molecules (oncogenes or tumor suppressor genes) contribute to the tumorigenic process, invasion, metastasis, and resistance to treatment. Based on recent evidence, the detection of molecular changes in these genes could have clinical importance for the early detection and evaluation of tumor grade, as well as the selection of targeted treatment. Researchers have recently focused on cancer stem cells (CSCs) in the treatment of gynecologic cancer because of their ability to induce progression and recurrence of malignancy. This has highlighted the importance of a better understanding of the molecular basis of CSCs. The purpose of this review is to focus on the molecular mechanism of gynecologic cancer and the role of CSCs to discover more specific therapeutic approaches to gynecologic cancer treatment."], "CopyrightInformation": "Copyright \u00a9 2022 Keyvani, Riahi, Yousefi, Esmaeili, Shafabakhsh, Moradi Hasan-Abad, Mahjoubin-Tehran, Hamblin, Mollazadeh and Mirzaei."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Keyvani", "ForeName": "Vahideh", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Mashhad, Iran; Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran."}], "LastName": "Riahi", "ForeName": "Espanta", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Yousefi", "ForeName": "Meysam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Esmaeili", "ForeName": "Seyed-Alireza", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Shafabakhsh", "ForeName": "Rana", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Moradi Hasan-Abad", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Mahjoubin-Tehran", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa."}], "LastName": "Hamblin", "ForeName": "Michael R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran."}, {"Identifier": [], "Affiliation": "Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran."}], "LastName": "Mirzaei", "ForeName": "Hamed", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmed N., Abubaker K., Findlay J., Quinn M. (2010). Epithelial Mesenchymal Transition and Cancer Stem Cell-like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer. Curr. Cancer Drug Targets 10 (3), 268\u2013278. 10.2174/156800910791190175", "ArticleIdList": ["10.2174/156800910791190175", "20370691"]}, {"Citation": "Ahn M. Y., Jung J. H., Na Y. J., Kim H. S. (2008). A Natural Histone Deacetylase Inhibitor, Psammaplin A, Induces Cell Cycle Arrest and Apoptosis in Human Endometrial Cancer Cells. Gynecol. Oncol. 108 (1), 27\u201333. 10.1016/j.ygyno.2007.08.098", "ArticleIdList": ["10.1016/j.ygyno.2007.08.098", "17920664"]}, {"Citation": "Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., Vergote I. (2005). Endometrial Cancer. Lancet 366 (9484), 491\u2013505. 10.1016/S0140-6736(05)67063-8", "ArticleIdList": ["10.1016/S0140-6736(05)67063-8", "16084259"]}, {"Citation": "Androutsopoulos G., Michail G., Adonakis G., Decavalas G. (2015). Current Treatment Approach of Endometrial Cancer. Int. J. Clin. Ther. Diagn. 1 (3), 8\u201311. 10.19070/2332-2926-SI01003", "ArticleIdList": ["10.19070/2332-2926-SI01003"]}, {"Citation": "Antoniou A., Pharoah P. D., Narod S., Risch H. A., Eyfjord J. E., Hopper J. L., et al. (2003). Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: a Combined Analysis of 22 Studies. Am. J. Hum. Genet. 72 (5), 1117\u20131130. 10.1086/375033", "ArticleIdList": ["10.1086/375033", "PMC1180265", "12677558"]}, {"Citation": "Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., et al. (2004). Tie2/angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche. Cell 118 (2), 149\u2013161. 10.1016/j.cell.2004.07.004", "ArticleIdList": ["10.1016/j.cell.2004.07.004", "15260986"]}, {"Citation": "Ayob A. Z., Ramasamy T. S. (2018). Cancer Stem Cells as Key Drivers of Tumour Progression. J. Biomed. Sci. 25 (1), 20\u201318. 10.1186/s12929-018-0426-4", "ArticleIdList": ["10.1186/s12929-018-0426-4", "PMC5838954", "29506506"]}, {"Citation": "Bach P., Abel T., Hoffmann C., Gal Z., Braun G., Voelker I., et al. (2013). Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus. Cancer Res. 73 (2), 865\u2013874. 10.1158/0008-5472.CAN-12-2221", "ArticleIdList": ["10.1158/0008-5472.CAN-12-2221", "23293278"]}, {"Citation": "Barnawi R., Al-Khaldi S., Majed Sleiman G., Sarkar A., Al-Dhfyan A., Al-Mohanna F., et al. (2016). Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway. Stem Cells 34 (12), 2799\u20132813. 10.1002/stem.2473", "ArticleIdList": ["10.1002/stem.2473", "27502039"]}, {"Citation": "Burger R. A., Brady M. F., Bookman M. A., Fleming G. F., Monk B. J., Huang H., et al. (2011). Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer. N. Engl. J. Med. 365 (26), 2473\u20132483. 10.1056/NEJMoa1104390", "ArticleIdList": ["10.1056/NEJMoa1104390", "22204724"]}, {"Citation": "Burk R. D., Chen Z., Van Doorslaer K. (2009). Human Papillomaviruses: Genetic Basis of Carcinogenicity. Public health genomics 12 (5-6), 281\u2013290. 10.1159/000214919", "ArticleIdList": ["10.1159/000214919", "PMC2835381", "19684441"]}, {"Citation": "Cancer IAfRo (2003). World Cancer Report: World Health Organization. Lyon: IARC Press."}, {"Citation": "Casagrande N., De Paoli M., Celegato M., Borghese C., Mongiat M., Colombatti A., et al. (2013). Preclinical Evaluation of a New Liposomal Formulation of Cisplatin, Lipoplatin, to Treat Cisplatin-Resistant Cervical Cancer. Gynecol. Oncol. 131 (3), 744\u2013752. 10.1016/j.ygyno.2013.08.041", "ArticleIdList": ["10.1016/j.ygyno.2013.08.041", "24029417"]}, {"Citation": "Chaudhry P., Asselin E. (2009). Resistance to Chemotherapy and Hormone Therapy in Endometrial Cancer. Endocr. Relat. Cancer 16 (2), 363\u2013380. 10.1677/ERC-08-0266", "ArticleIdList": ["10.1677/ERC-08-0266", "19190080"]}, {"Citation": "Chen H. X., Liu Y. J., Zhou X. D., Luo R. Y. (2005). Expression of Cellular FLICE/caspase-8 Inhibitory Protein Is Associated with Malignant Potential in Endometrial Carcinoma. Int. J. Gynecol. Cancer 15 (4), 663\u2013670. 10.1111/j.1525-1438.2005.00122.x", "ArticleIdList": ["10.1111/j.1525-1438.2005.00122.x", "16014121"]}, {"Citation": "Chen J., Wang J., Chen D., Yang J., Yang C., Zhang Y., et al. (2013). Evaluation of Characteristics of CD44+CD117+ Ovarian Cancer Stem Cells in Three Dimensional Basement Membrane Extract Scaffold versus Two Dimensional Monocultures. BMC Cell Biol 14, 7. 10.1186/1471-2121-14-7", "ArticleIdList": ["10.1186/1471-2121-14-7", "PMC3565868", "23368632"]}, {"Citation": "Ch\u00e9reau E., Lambaudie E., Houvenaeghel G. (2013). Morbidity of Surgery after Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer. Int. J. Gynecol. Cancer 23 (7), 1326\u20131330. 10.1097/IGC.0b013e31829dc923", "ArticleIdList": ["10.1097/IGC.0b013e31829dc923", "23835506"]}, {"Citation": "Collado M., Serrano M. (2010). Senescence in Tumours: Evidence from Mice and Humans. Nat. Rev. Cancer 10 (1), 51\u201357. 10.1038/nrc2772", "ArticleIdList": ["10.1038/nrc2772", "PMC3672965", "20029423"]}, {"Citation": "Cooke S. L., Temple J., Macarthur S., Zahra M. A., Tan L. T., Crawford R. A., et al. (2011). Intra-tumour Genetic Heterogeneity and Poor Chemoradiotherapy Response in Cervical Cancer. Br. J. Cancer 104 (2), 361\u2013368. 10.1038/sj.bjc.6605971", "ArticleIdList": ["10.1038/sj.bjc.6605971", "PMC3031882", "21063398"]}, {"Citation": "Croce C. M. (2008). Oncogenes and Cancer. N. Engl. J. Med. 358 (5), 502\u2013511. 10.1056/nejmra072367", "ArticleIdList": ["10.1056/nejmra072367", "18234754"]}, {"Citation": "Davis G. E., Senger D. R. (2005). Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions during Vascular Morphogenesis and Neovessel Stabilization. Circ. Res. 97 (11), 1093\u20131107. 10.1161/01.RES.0000191547.64391.e3", "ArticleIdList": ["10.1161/01.RES.0000191547.64391.e3", "16306453"]}, {"Citation": "Dean M., Fojo T., Bates S. (2005). Tumour Stem Cells and Drug Resistance. Nat. Rev. Cancer 5 (4), 275\u2013284. 10.1038/nrc1590", "ArticleIdList": ["10.1038/nrc1590", "15803154"]}, {"Citation": "Desai A., Yan Y., Gerson S. L. (2019). Concise Reviews: Cancer Stem Cell Targeted Therapies: toward Clinical success. Stem Cell Transl Med 8 (1), 75\u201381. 10.1002/sctm.18-0123", "ArticleIdList": ["10.1002/sctm.18-0123", "PMC6312440", "30328686"]}, {"Citation": "Doroshow J. H., Kummar S. (2014). Translational Research in Oncology--10 Years of Progress and Future Prospects. Nat. Rev. Clin. Oncol. 11 (11), 649\u2013662. 10.1038/nrclinonc.2014.158", "ArticleIdList": ["10.1038/nrclinonc.2014.158", "25286976"]}, {"Citation": "Dou Q. Q., Rengaramchandran A., Selvan S. T., Paulmurugan R., Zhang Y. (2015). Core-shell Upconversion Nanoparticle - Semiconductor Heterostructures for Photodynamic Therapy. Sci. Rep. 5, 8252. 10.1038/srep08252", "ArticleIdList": ["10.1038/srep08252", "PMC4317689", "25652742"]}, {"Citation": "Dragu D. L., Necula L. G., Bleotu C., Diaconu C. C., Chivu-Economescu M. (2015). Therapies Targeting Cancer Stem Cells: Current Trends and Future Challenges. World J. Stem Cell 7 (9), 1185\u20131201. 10.4252/wjsc.v7.i9.1185", "ArticleIdList": ["10.4252/wjsc.v7.i9.1185", "PMC4620424", "26516409"]}, {"Citation": "Drayton R. M. (2012). The Role of microRNA in the Response to Cisplatin Treatment. Biochem. Soc. Trans. 40 (4), 821\u2013825. 10.1042/BST20120055", "ArticleIdList": ["10.1042/BST20120055", "22817741"]}, {"Citation": "Fujita T., Miyamoto S., Onoyama I., Sonoda K., Mekada E., Nakano H. (2003). Expression of Lysophosphatidic Acid Receptors and Vascular Endothelial Growth Factor Mediating Lysophosphatidic Acid in the Development of Human Ovarian Cancer. Cancer Lett. 192 (2), 161\u2013169. 10.1016/s0304-3835(02)00713-9", "ArticleIdList": ["10.1016/s0304-3835(02)00713-9", "12668280"]}, {"Citation": "Galluzzi L., Senovilla L., Vitale I., Michels J., Martins I., Kepp O., et al. (2012). Molecular Mechanisms of Cisplatin Resistance. Oncogene 31 (15), 1869\u20131883. 10.1038/onc.2011.384", "ArticleIdList": ["10.1038/onc.2011.384", "21892204"]}, {"Citation": "Garzia L., Andolfo I., Cusanelli E., Marino N., Petrosino G., De Martino D., et al. (2009). MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma. PloS one 4 (3), e4998. 10.1371/journal.pone.0004998", "ArticleIdList": ["10.1371/journal.pone.0004998", "PMC2656623", "19308264"]}, {"Citation": "George S. H., Shaw P. (2014). BRCA and Early Events in the Development of Serous Ovarian Cancer. Front. Oncol. 4, 5. 10.3389/fonc.2014.00005", "ArticleIdList": ["10.3389/fonc.2014.00005", "PMC3901362", "24478985"]}, {"Citation": "Giarnieri E., Zanesi N., Bottoni A., Alderisio M., Lukic A., Vecchione A., et al. (2010). Oncosuppressor Proteins of Fragile Sites Are Reduced in Cervical Cancer. Cancer Lett. 289 (1), 40\u201345. 10.1016/j.canlet.2009.07.017", "ArticleIdList": ["10.1016/j.canlet.2009.07.017", "PMC2987609", "19700237"]}, {"Citation": "Gillet J.-P., Gottesman M. M. (2010). \u201cMechanisms of Multidrug Resistance in Cancer,\u201d in Multi-drug Resistance in Cancer (Berlin: Springer; ), 47\u201376. 10.1007/978-1-60761-416-6_4", "ArticleIdList": ["10.1007/978-1-60761-416-6_4", "19949920"]}, {"Citation": "Grever M. R., Schepartz S. A., Chabner B. A. (1992). The National Cancer Institute: Cancer Drug Discovery and Development Program. Semin. Oncol. 19, 622\u2013638.", "ArticleIdList": ["1462164"]}, {"Citation": "Grosse-Gehling P., Fargeas C. A., Dittfeld C., Garbe Y., Alison M. R., Corbeil D., et al. (2013). CD133 as a Biomarker for Putative Cancer Stem Cells in Solid Tumours: Limitations, Problems and Challenges. J. Pathol. 229 (3), 355\u2013378. 10.1002/path.4086", "ArticleIdList": ["10.1002/path.4086", "22899341"]}, {"Citation": "Gui T., Cao D., Yang J., Shen K. (2015). Tumor Heterogeneity Has Important Consequences for Personalized Medicine in Ovarian Cancer. Histol. Histopathol 30, 173\u2013181. 10.14670/HH-30.173", "ArticleIdList": ["10.14670/HH-30.173", "25058000"]}, {"Citation": "Halperin R., Zehavi S., Habler L., Hadas E., Bukovsky I., Schneider D. (2001). Comparative Immunohistochemical Study of Endometrioid and Serous Papillary Carcinoma of Endometrium. Eur. J. Gynaecol. Oncol. 22 (2), 122\u2013126.", "ArticleIdList": ["11446475"]}, {"Citation": "Hanahan D., Weinberg R. A. (2011). Hallmarks of Cancer: the Next Generation. cell 144 (5), 646\u2013674. 10.1016/j.cell.2011.02.013", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Harris C. P., Lu X. Y., Narayan G., Singh B., Murty V. V., Rao P. H. (2003). Comprehensive Molecular Cytogenetic Characterization of Cervical Cancer Cell Lines. Genes Chromosomes Cancer 36 (3), 233\u2013241. 10.1002/gcc.10158", "ArticleIdList": ["10.1002/gcc.10158", "12557223"]}, {"Citation": "Harris S. L., Levine A. J. (2005). The P53 Pathway: Positive and Negative Feedback Loops. Oncogene 24 (17), 2899\u20132908. 10.1038/sj.onc.1208615", "ArticleIdList": ["10.1038/sj.onc.1208615", "15838523"]}, {"Citation": "Hecht J. L., Mutter G. L. (2006). Molecular and Pathologic Aspects of Endometrial Carcinogenesis. J. Clin. Oncol. 24 (29), 4783\u20134791. 10.1200/JCO.2006.06.7173", "ArticleIdList": ["10.1200/JCO.2006.06.7173", "17028294"]}, {"Citation": "Hirsch D., Barker N., McNeil N., Hu Y., Camps J., McKinnon K., et al. (2014). LGR5 Positivity Defines Stem-like Cells in Colorectal Cancer. Carcinogenesis 35 (4), 849\u2013858. 10.1093/carcin/bgt377", "ArticleIdList": ["10.1093/carcin/bgt377", "PMC3977143", "24282287"]}, {"Citation": "Holcomb K., Delatorre R., Pedemonte B., McLeod C., Anderson L., Chambers J. (2002). E-cadherin Expression in Endometrioid, Papillary Serous, and clear Cell Carcinoma of the Endometrium. Obstet. Gynecol. 100 (6), 1290\u20131295. 10.1016/s0029-7844(02)02391-8", "ArticleIdList": ["10.1016/s0029-7844(02)02391-8", "12468176"]}, {"Citation": "Hong I. S., Jang G. B., Lee H. Y., Nam J. S. (2015). Targeting Cancer Stem Cells by Using the Nanoparticles. Int. J. Nanomedicine 10 (Spec Iss), 251\u2013260. 10.2147/IJN.S88310", "ArticleIdList": ["10.2147/IJN.S88310", "PMC4583536", "26425092"]}, {"Citation": "Hovinga K. E., Shimizu F., Wang R., Panagiotakos G., Van Der Heijden M., Moayedpardazi H., et al. (2010). Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate. Stem cells 28 (6), 1019\u20131029. 10.1002/stem.429", "ArticleIdList": ["10.1002/stem.429", "PMC5532884", "20506127"]}, {"Citation": "Hu L., McArthur C., Jaffe R. B. (2010). Ovarian Cancer Stem-like Side-Population Cells Are Tumourigenic and Chemoresistant. Br. J. Cancer 102 (8), 1276\u20131283. 10.1038/sj.bjc.6605626", "ArticleIdList": ["10.1038/sj.bjc.6605626", "PMC2856005", "20354527"]}, {"Citation": "Hua H., Li M., Luo T., Yin Y., Jiang Y. (2011). Matrix Metalloproteinases in Tumorigenesis: an Evolving Paradigm. Cell Mol Life Sci 68 (23), 3853\u20133868. 10.1007/s00018-011-0763-x", "ArticleIdList": ["10.1007/s00018-011-0763-x", "21744247"]}, {"Citation": "Huang K. F., Lee W. Y., Huang S. C., Lin Y. S., Kang C. Y., Liou C. P., et al. (2007). Chromosomal Gain of 3q and Loss of 11q Often Associated with Nodal Metastasis in Early Stage Cervical Squamous Cell Carcinoma. J. Formos. Med. Assoc. 106 (11), 894\u2013902. 10.1016/S0929-6646(08)60059-5", "ArticleIdList": ["10.1016/S0929-6646(08)60059-5", "18063510"]}, {"Citation": "Islam F., Gopalan V., Smith R. A., Lam A. K. (2015). Translational Potential of Cancer Stem Cells: A Review of the Detection of Cancer Stem Cells and Their Roles in Cancer Recurrence and Cancer Treatment. Exp. Cell Res 335 (1), 135\u2013147. 10.1016/j.yexcr.2015.04.018", "ArticleIdList": ["10.1016/j.yexcr.2015.04.018", "25967525"]}, {"Citation": "Jiang S., Dowdy S. C., Meng X. W., Wang Z., Jones M. B., Podratz K. C., et al. (2007). Histone Deacetylase Inhibitors Induce Apoptosis in Both Type I and Type II Endometrial Cancer Cells. Gynecol. Oncol. 105 (2), 493\u2013500. 10.1016/j.ygyno.2007.01.012", "ArticleIdList": ["10.1016/j.ygyno.2007.01.012", "PMC3273418", "17303224"]}, {"Citation": "Kamazawa S., Kigawa J., Kanamori Y., Itamochi H., Sato S., Iba T., et al. (2002). Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer. Gynecol. Oncol. 86 (2), 171\u2013176. 10.1006/gyno.2002.6738", "ArticleIdList": ["10.1006/gyno.2002.6738", "12144824"]}, {"Citation": "Kato S., Sadarangani A., Lange S., Villal\u00f3n M., Bra\u00f1es J., Brosens J. J., et al. (2007). The Oestrogen Metabolite 2-methoxyoestradiol Alone or in Combination with Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand Mediates Apoptosis in Cancerous but Not Healthy Cells of the Human Endometrium. Endocr. Relat. Cancer 14 (2), 351\u2013368. 10.1677/ERC-07-0008", "ArticleIdList": ["10.1677/ERC-07-0008", "PMC6112420", "17639050"]}, {"Citation": "Kemper K., Prasetyanti P. R., De Lau W., Rodermond H., Clevers H., Medema J. P. (2012). Monoclonal Antibodies against Lgr5 Identify Human Colorectal Cancer Stem Cells. Stem Cells 30 (11), 2378\u20132386. 10.1002/stem.1233", "ArticleIdList": ["10.1002/stem.1233", "22969042"]}, {"Citation": "Kenda Suster N., Virant-Klun I. (2019). Presence and Role of Stem Cells in Ovarian Cancer. World J. Stem Cell 11 (7), 383\u2013397. 10.4252/wjsc.v11.i7.383", "ArticleIdList": ["10.4252/wjsc.v11.i7.383", "PMC6682502", "31396367"]}, {"Citation": "Keyvani V., Farshchian M., Esmaeili S. A., Yari H., Moghbeli M., Nezhad S. K., et al. (2019). Ovarian Cancer Stem Cells and Targeted Therapy. J. Ovarian Res. 12 (1), 120. 10.1186/s13048-019-0588-z", "ArticleIdList": ["10.1186/s13048-019-0588-z", "PMC6896744", "31810474"]}, {"Citation": "Kidd E. A., Grigsby P. W. (2008). Intratumoral Metabolic Heterogeneity of Cervical Cancer. Clin. Cancer Res. 14 (16), 5236\u20135241. 10.1158/1078-0432.CCR-07-5252", "ArticleIdList": ["10.1158/1078-0432.CCR-07-5252", "18698042"]}, {"Citation": "Kim K. S., Park W., Na K. (2015). Gadolinium-chelate Nanoparticle Entrapped Human Mesenchymal Stem Cell via Photochemical Internalization for Cancer Diagnosis. Biomaterials 36, 90\u201397. 10.1016/j.biomaterials.2014.09.014", "ArticleIdList": ["10.1016/j.biomaterials.2014.09.014", "25301637"]}, {"Citation": "Kim W. T., Ryu C. J. (2017). Cancer Stem Cell Surface Markers on normal Stem Cells. BMB Rep. 50 (6), 285\u2013298. 10.5483/bmbrep.2017.50.6.039", "ArticleIdList": ["10.5483/bmbrep.2017.50.6.039", "PMC5498139", "28270302"]}, {"Citation": "Kyo S. (2013). Endometrial Cancer Stem Cells: Are They a Possible Therapeutic Target? Curr. Obstet. Gynecol. Rep. 2 (1), 1\u201310. 10.1007/s13669-012-0030-7", "ArticleIdList": ["10.1007/s13669-012-0030-7"]}, {"Citation": "Landen C. N., Jr, Birrer M. J., Sood A. K. (2008). Early Events in the Pathogenesis of Epithelial Ovarian Cancer. J. Clin. Oncol. 26 (6), 995\u20131005. 10.1200/JCO.2006.07.9970", "ArticleIdList": ["10.1200/JCO.2006.07.9970", "18195328"]}, {"Citation": "Ledermann J., Harter P., Gourley C., Friedlander M., Vergote I., Rustin G., et al. (2012). Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer. N. Engl. J. Med. 366 (15), 1382\u20131392. 10.1056/NEJMoa1105535", "ArticleIdList": ["10.1056/NEJMoa1105535", "22452356"]}, {"Citation": "Lengyel E. (2010). Ovarian Cancer Development and Metastasis. Am. J. Pathol. 177 (3), 1053\u20131064. 10.2353/ajpath.2010.100105", "ArticleIdList": ["10.2353/ajpath.2010.100105", "PMC2928939", "20651229"]}, {"Citation": "Liby T. A., Spyropoulos P., Buff Lindner H., Eldridge J., Beeson C., Hsu T., et al. (2012). Akt3 Controls Vascular Endothelial Growth Factor Secretion and Angiogenesis in Ovarian Cancer Cells. Int. J. Cancer 130 (3), 532\u2013543. 10.1002/ijc.26010", "ArticleIdList": ["10.1002/ijc.26010", "PMC3189303", "21351097"]}, {"Citation": "Liu J., Cao L., Chen J., Song S., Lee I. H., Quijano C., et al. (2009). Bmi1 Regulates Mitochondrial Function and the DNA Damage Response Pathway. Nature 459 (7245), 387\u2013392. 10.1038/nature08040", "ArticleIdList": ["10.1038/nature08040", "PMC4721521", "19404261"]}, {"Citation": "Liu J. F., Konstantinopoulos P. A., Matulonis U. A. (2014). PARP Inhibitors in Ovarian Cancer: Current Status and Future Promise. Gynecol. Oncol. 133 (2), 362\u2013369. 10.1016/j.ygyno.2014.02.039", "ArticleIdList": ["10.1016/j.ygyno.2014.02.039", "24607283"]}, {"Citation": "Liu S. Y., Zheng P. S. (2013). High Aldehyde Dehydrogenase Activity Identifies Cancer Stem Cells in Human Cervical Cancer. Oncotarget 4 (12), 2462\u20132475. 10.18632/oncotarget.1578", "ArticleIdList": ["10.18632/oncotarget.1578", "PMC3926841", "24318570"]}, {"Citation": "L\u00f3pez J., Poitevin A., Mendoza-Mart\u00ednez V., P\u00e9rez-Plasencia C., Garc\u00eda-Carranc\u00e1 A. (2012). Cancer-initiating Cells Derived from Established Cervical Cell Lines Exhibit Stem-Cell Markers and Increased Radioresistance. BMC cancer 12 (1), 48. 10.1186/1471-2407-12-48", "ArticleIdList": ["10.1186/1471-2407-12-48", "PMC3299592", "22284662"]}, {"Citation": "Lu D., Choi M. Y., Yu J., Castro J. E., Kipps T. J., Carson D. A. (2011). Salinomycin Inhibits Wnt Signaling and Selectively Induces Apoptosis in Chronic Lymphocytic Leukemia Cells. Proc. Natl. Acad. Sci. U S A. 108 (32), 13253\u201313257. 10.1073/pnas.1110431108", "ArticleIdList": ["10.1073/pnas.1110431108", "PMC3156152", "21788521"]}, {"Citation": "MacDonald N. D., Salvesen H. B., Ryan A., Iversen O. E., Akslen L. A., Jacobs I. J. (2000). Frequency and Prognostic Impact of Microsatellite Instability in a Large Population-Based Study of Endometrial Carcinomas. Cancer Res. 60 (6), 1750\u20131752.", "ArticleIdList": ["10749149"]}, {"Citation": "Mammas I. N., Sourvinos G., Giannoudis A., Spandidos D. A. (2008). Human Papilloma Virus (HPV) and Host Cellular Interactions. Pathol. Oncol. Res. 14 (4), 345\u2013354. 10.1007/s12253-008-9056-6", "ArticleIdList": ["10.1007/s12253-008-9056-6", "18493868"]}, {"Citation": "Matias-Guiu X., Prat J. (2013). Molecular Pathology of Endometrial Carcinoma. Histopathology 62 (1), 111\u2013123. 10.1111/his.12053", "ArticleIdList": ["10.1111/his.12053", "23240673"]}, {"Citation": "Matias-Guiu X., Catasus L., Bussaglia E., Lagarda H., Garcia A., Pons C., et al. (2001). Molecular Pathology of Endometrial Hyperplasia and Carcinoma. Hum. Pathol. 32 (6), 569\u2013577. 10.1053/hupa.2001.25929", "ArticleIdList": ["10.1053/hupa.2001.25929", "11431710"]}, {"Citation": "Mayr D., Hirschmann A., L\u00f6hrs U., Diebold J. (2006). KRAS and BRAF Mutations in Ovarian Tumors: a Comprehensive Study of Invasive Carcinomas, Borderline Tumors and Extraovarian Implants. Gynecol. Oncol. 103 (3), 883\u2013887. 10.1016/j.ygyno.2006.05.029", "ArticleIdList": ["10.1016/j.ygyno.2006.05.029", "16806438"]}, {"Citation": "McLaughlin J. R., Risch H. A., Lubinski J., Moller P., Ghadirian P., Lynch H., et al. (2007). Reproductive Risk Factors for Ovarian Cancer in Carriers of BRCA1 or BRCA2 Mutations: a Case-Control Study. Lancet Oncol. 8 (1), 26\u201334. 10.1016/S1470-2045(06)70983-4", "ArticleIdList": ["10.1016/S1470-2045(06)70983-4", "17196508"]}, {"Citation": "Meacham C. E., Morrison S. J. (2013). Tumour Heterogeneity and Cancer Cell Plasticity. Nature 501 (7467), 328\u2013337. 10.1038/nature12624", "ArticleIdList": ["10.1038/nature12624", "PMC4521623", "24048065"]}, {"Citation": "Meyer L. A., Broaddus R. R., Lu K. H. (2009). Endometrial Cancer and Lynch Syndrome: Clinical and Pathologic Considerations. Cancer Control 16 (1), 14\u201322. 10.1177/107327480901600103", "ArticleIdList": ["10.1177/107327480901600103", "PMC3693757", "19078925"]}, {"Citation": "Milanesio M. C., Giordano S., Valabrega G. (2020). Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas. Cancers (Basel) 12 (5), 1315. 10.3390/cancers12051315", "ArticleIdList": ["10.3390/cancers12051315", "PMC7281678", "32455819"]}, {"Citation": "Moghbeli M., Moghbeli F., Forghanifard M. M., Abbaszadegan M. R. (2014). Cancer Stem Cell Detection and Isolation. Med. Oncol. 31 (9), 69. 10.1007/s12032-014-0069-6", "ArticleIdList": ["10.1007/s12032-014-0069-6", "25064729"]}, {"Citation": "Moghbeli M., Mosannen Mozaffari H., Memar B., Forghanifard M. M., Gholamin M., Abbaszadegan M. R. (2019). Role of MAML1 in Targeted Therapy against the Esophageal Cancer Stem Cells. J. Transl Med. 17 (1), 126. 10.1186/s12967-019-1876-5", "ArticleIdList": ["10.1186/s12967-019-1876-5", "PMC6469193", "30992079"]}, {"Citation": "M\u00f8ller P. (2005). Genotoxicity of Environmental Agents Assessed by the Alkaline Comet Assay. Basic Clin. Pharmacol. Toxicol. 96, 1\u201342.", "ArticleIdList": ["15859009"]}, {"Citation": "Moody C. A., Laimins L. A. (2010). Human Papillomavirus Oncoproteins: Pathways to Transformation. Nat. Rev. Cancer 10 (8), 550\u2013560. 10.1038/nrc2886", "ArticleIdList": ["10.1038/nrc2886", "20592731"]}, {"Citation": "Morice P., Leary A., Creutzberg C., Abu-Rustum N., Darai E. (2016). Endometrial Cancer. Lancet 387 (10023), 1094\u20131108. 10.1016/S0140-6736(15)00130-0", "ArticleIdList": ["10.1016/S0140-6736(15)00130-0", "26354523"]}, {"Citation": "Mukherjee D., Zhao J. (2013). The Role of Chemokine Receptor CXCR4 in Breast Cancer Metastasis. Am. J. Cancer Res. 3 (1), 46\u201357.", "ArticleIdList": ["PMC3555200", "23359227"]}, {"Citation": "Negrini S., Gorgoulis V. G., Halazonetis T. D. (2010). Genomic Instability-Aan Evolving Hallmark of Cancer. Nat. Rev. Mol. Cell Biol 11 (3), 220\u2013228. 10.1038/nrm2858", "ArticleIdList": ["10.1038/nrm2858", "20177397"]}, {"Citation": "Niwa K., Murase T., Furui T., Morishita S., Mori H., Tanaka T., et al. (1993). Enhancing Effects of Estrogens on Endometrial Carcinogenesis Initiated by N-Methyl-N-Nitrosourea in ICR Mice. Jpn. J. Cancer Res. 84 (9), 951\u2013955. 10.1111/j.1349-7006.1993.tb00183.x", "ArticleIdList": ["10.1111/j.1349-7006.1993.tb00183.x", "PMC5919289", "8407561"]}, {"Citation": "Nowee M. E., Snijders A. M., Rockx D. A., de Wit R. M., Kosma V. M., H\u00e4m\u00e4l\u00e4inen K., et al. (2007). DNA Profiling of Primary Serous Ovarian and Fallopian Tube Carcinomas with Array Comparative Genomic Hybridization and Multiplex Ligation-dependent Probe Amplification. J. Pathol. 213 (1), 46\u201355. 10.1002/path.2217", "ArticleIdList": ["10.1002/path.2217", "17668415"]}, {"Citation": "O'Neill C. J., Deavers M. T., Malpica A., Foster H., McCluggage W. G. (2005). An Immunohistochemical Comparison between Low-Grade and High-Grade Ovarian Serous Carcinomas: Significantly Higher Expression of P53, MIB1, BCL2, HER-2/neu, and C-KIT in High-Grade Neoplasms. Am. J. Surg. Pathol. 29 (8), 1034\u20131041. 10.1097/01.pas.0000166367.68459.7d", "ArticleIdList": ["10.1097/01.pas.0000166367.68459.7d", "16006797"]}, {"Citation": "Planagum\u00e0 J., Liljestr\u00f6m M., Alameda F., B\u00fctzow R., Virtanen I., Revent\u00f3s J., et al. (2011). Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Codistribute with Transcription Factors RUNX1/AML1 and ETV5/ERM at the Invasive Front of Endometrial and Ovarian Carcinoma. Hum. Pathol. 42 (1), 57\u201367. 10.1016/j.humpath.2010.01.025", "ArticleIdList": ["10.1016/j.humpath.2010.01.025", "20970160"]}, {"Citation": "Pouliot L. M., Shen D. W., Suzuki T., Hall M. D., Gottesman M. M. (2013). Contributions of microRNA Dysregulation to Cisplatin Resistance in Adenocarcinoma Cells. Exp. Cell Res 319 (4), 566\u2013574. 10.1016/j.yexcr.2012.10.012", "ArticleIdList": ["10.1016/j.yexcr.2012.10.012", "PMC3563763", "23137650"]}, {"Citation": "Powell S. N., Kachnic L. A. (2003). Roles of BRCA1 and BRCA2 in Homologous Recombination, DNA Replication Fidelity and the Cellular Response to Ionizing Radiation. Oncogene 22 (37), 5784\u20135791. 10.1038/sj.onc.1206678", "ArticleIdList": ["10.1038/sj.onc.1206678", "12947386"]}, {"Citation": "Przybylo J. A., Radisky D. C. (2007). Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition: Tumor Progression at Snail's Pace. Int. J. Biochem. Cell Biol 39 (6), 1082\u20131088. 10.1016/j.biocel.2007.03.002", "ArticleIdList": ["10.1016/j.biocel.2007.03.002", "17416542"]}, {"Citation": "Rao W., Wang H., Han J., Zhao S., Dumbleton J., Agarwal P., et al. (2015). Chitosan-decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells. ACS nano 9 (6), 5725\u20135740. 10.1021/nn506928p", "ArticleIdList": ["10.1021/nn506928p", "26004286"]}, {"Citation": "Rauh-Hain J. A., Del Carmen M. G. (2010). Treatment for Advanced and Recurrent Endometrial Carcinoma: Combined Modalities. Oncologist 15 (8), 852\u2013861. 10.1634/theoncologist.2010-0091", "ArticleIdList": ["10.1634/theoncologist.2010-0091", "PMC3228028", "20660059"]}, {"Citation": "Risch H. A., McLaughlin J. R., Cole D. E., Rosen B., Bradley L., Kwan E., et al. (2001). Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer. Am. J. Hum. Genet. 68 (3), 700\u2013710. 10.1086/318787", "ArticleIdList": ["10.1086/318787", "PMC1274482", "11179017"]}, {"Citation": "Rotherham M., El Haj A. J. (2015). Remote Activation of the Wnt/\u03b2-Catenin Signalling Pathway Using Functionalised Magnetic Particles. PloS one 10 (3), e0121761. 10.1371/journal.pone.0121761", "ArticleIdList": ["10.1371/journal.pone.0121761", "PMC4363733", "25781466"]}, {"Citation": "Sadarangani A., Kato S., Espinoza N., Lange S., Llados C., Espinosa M., et al. (2007). TRAIL Mediates Apoptosis in Cancerous but Not normal Primary Cultured Cells of the Human Reproductive Tract. Apoptosis 12 (1), 73\u201385. 10.1007/s10495-006-0492-z", "ArticleIdList": ["10.1007/s10495-006-0492-z", "17136491"]}, {"Citation": "Sawada K., Mitra A. K., Radjabi A. R., Bhaskar V., Kistner E. O., Tretiakova M., et al. (2008). Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via Alpha 5-integrin, Which Is a Therapeutic Target. Cancer Res. 68 (7), 2329\u20132339. 10.1158/0008-5472.CAN-07-5167", "ArticleIdList": ["10.1158/0008-5472.CAN-07-5167", "PMC2665934", "18381440"]}, {"Citation": "Schiffman M., Castle P. E., Jeronimo J., Rodriguez A. C., Wacholder S. (2007). Human Papillomavirus and Cervical Cancer. Lancet 370 (9590), 890\u2013907. 10.1016/S0140-6736(07)61416-0", "ArticleIdList": ["10.1016/S0140-6736(07)61416-0", "17826171"]}, {"Citation": "Schmitt M. W., Prindle M. J., Loeb L. A. (2012). Implications of Genetic Heterogeneity in Cancer. Ann. N. Y Acad. Sci. 1267, 110\u2013116. 10.1111/j.1749-6632.2012.06590.x", "ArticleIdList": ["10.1111/j.1749-6632.2012.06590.x", "PMC3674777", "22954224"]}, {"Citation": "Schmohl J. U., Vallera D. A. (2016). CD133, Selectively Targeting the Root of Cancer. Toxins (Basel) 8 (6). 10.3390/toxins8060165", "ArticleIdList": ["10.3390/toxins8060165", "PMC4926132", "27240402"]}, {"Citation": "Shen D. W., Pouliot L. M., Hall M. D., Gottesman M. M. (2012). Cisplatin Resistance: a Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes. Pharmacol. Rev. 64 (3), 706\u2013721. 10.1124/pr.111.005637", "ArticleIdList": ["10.1124/pr.111.005637", "PMC3400836", "22659329"]}, {"Citation": "Siegel R., Naishadham D., Jemal A. (2012). Cancer Statistics, 2012. CA Cancer J. Clin. 62 (5), 10\u201329. 10.3322/caac.20138", "ArticleIdList": ["10.3322/caac.20138", "22237781"]}, {"Citation": "Skubitz A. P., Taras E. P., Boylan K. L., Waldron N. N., Oh S., Panoskaltsis-Mortari A., et al. (2013). Targeting CD133 in an In Vivo Ovarian Cancer Model Reduces Ovarian Cancer Progression. Gynecol. Oncol. 130 (3), 579\u2013587. 10.1016/j.ygyno.2013.05.027", "ArticleIdList": ["10.1016/j.ygyno.2013.05.027", "PMC3906852", "23721800"]}, {"Citation": "Sonoda K., Kaku T., Hirakawa T., Kobayashi H., Amada S., Sakai K., et al. (2000). The Clinical Significance of Tumor-Associated Antigen RCAS1 Expression in the normal, Hyperplastic, and Malignant Uterine Endometrium. Gynecol. Oncol. 79 (3), 424\u2013429. 10.1006/gyno.2000.5981", "ArticleIdList": ["10.1006/gyno.2000.5981", "11104614"]}, {"Citation": "Sonoda K., Kaku T., Kamura T., Nakashima M., Watanabe T., Nakano H. (1998). Tumor-associated Antigen 22-1-1 Expression in the Uterine Cervical Squamous Neoplasias. Clin. Cancer Res. 4 (6), 1517\u20131520.", "ArticleIdList": ["9626471"]}, {"Citation": "Sonoda K., Miyamoto S., Hirakawa T., Kaku T., Nakashima M., Watanabe T., et al. (2003). Association between RCAS1 Expression and Clinical Outcome in Uterine Endometrial Cancer. Br. J. Cancer 89 (3), 546\u2013551. 10.1038/sj.bjc.6601126", "ArticleIdList": ["10.1038/sj.bjc.6601126", "PMC2394364", "12888828"]}, {"Citation": "Sonoda K., Miyamoto S., Hirakawa T., Yagi H., Yotsumoto F., Nakashima M., et al. (2005). Invasive Potency Related to RCAS1 Expression in Uterine Cervical Cancer. Gynecol. Oncol. 99 (1), 189\u2013198. 10.1016/j.ygyno.2005.06.061", "ArticleIdList": ["10.1016/j.ygyno.2005.06.061", "16112176"]}, {"Citation": "Sonoda K., Miyamoto S., Yamazaki A., Kobayashi H., Nakashima M., Mekada E., et al. (2007). Biologic Significance of Receptor-Binding Cancer Antigen Expressed on SiSo Cells (RCAS1) as a Pivotal Regulator of Tumor Growth through Angiogenesis in Human Uterine Cancer. Cancer 110 (9), 1979\u20131990. 10.1002/cncr.23015", "ArticleIdList": ["10.1002/cncr.23015", "17849467"]}, {"Citation": "Sonoda K. (2016). Molecular Biology of Gynecological Cancer. Oncol. Lett. 11 (1), 16\u201322. 10.3892/ol.2015.3862", "ArticleIdList": ["10.3892/ol.2015.3862", "PMC4727069", "26834851"]}, {"Citation": "Spandidos D. A., Dokianakis D. N., Kallergi G., Aggelakis E. (2000). Molecular Basis of Gynecological Cancer. Ann. N. Y Acad. Sci. 900 (1), 56\u201364. 10.1111/j.1749-6632.2000.tb06216.x", "ArticleIdList": ["10.1111/j.1749-6632.2000.tb06216.x", "10818392"]}, {"Citation": "Su Z., Yang Z., Xu Y., Chen Y., Yu Q. (2015). Apoptosis, Autophagy, Necroptosis, and Cancer Metastasis. Mol. Cancer 14 (1), 48. 10.1186/s12943-015-0321-5", "ArticleIdList": ["10.1186/s12943-015-0321-5", "PMC4343053", "25743109"]}, {"Citation": "Sudhalkar N., Rathod N. P., Mathews A., Chopra S., Sriram H., Shrivastava S. K., et al. (2019). Potential Role of Cancer Stem Cells as Biomarkers and Therapeutic Targets in Cervical Cancer. Cancer Rep. (Hoboken) 2 (2), e1144. 10.1002/cnr2.1144", "ArticleIdList": ["10.1002/cnr2.1144", "PMC7941515", "32721115"]}, {"Citation": "Takai N., Desmond J. C., Kumagai T., Gui D., Said J. W., Whittaker S., et al. (2004). Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells. Clin. Cancer Res. 10 (3), 1141\u20131149. 10.1158/1078-0432.ccr-03-0100", "ArticleIdList": ["10.1158/1078-0432.ccr-03-0100", "14871994"]}, {"Citation": "Torii Y., Kato R., Minami Y., Hasegawa K., Fujii T., Udagawa Y. (2014). ERCC1 Expression and Chemosensitivity in Uterine Cervical Adenocarcinoma Cells. Anticancer Res. 34 (1), 107\u2013115.", "ArticleIdList": ["24403450"]}, {"Citation": "Venkitaraman A. R. (2009). Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment. Annu. Rev. Pathol. 4, 461\u2013487. 10.1146/annurev.pathol.3.121806.151422", "ArticleIdList": ["10.1146/annurev.pathol.3.121806.151422", "18954285"]}, {"Citation": "Vicente-Due\u00f1as C., Romero\u2010Camarero I., Cobaleda C., S\u00e1nchez\u2010Garc\u00eda I. (2013). Function of Oncogenes in Cancer Development: a Changing Paradigm. EMBO J. 32 (11), 1502\u20131513. 10.1038/emboj.2013.97", "ArticleIdList": ["10.1038/emboj.2013.97", "PMC3671260", "23632857"]}, {"Citation": "Walcher L., Kistenmacher A. K., Suo H., Kitte R., Dluczek S., Strau\u00df A., et al. (2020). Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front. Immunol. 11 (1280), 1280. 10.3389/fimmu.2020.01280", "ArticleIdList": ["10.3389/fimmu.2020.01280", "PMC7426526", "32849491"]}, {"Citation": "Wallace-Brodeur R. R., Lowe S. W. (1999). Clinical Implications of P53 Mutations. Cell Mol Life Sci 55 (1), 64\u201375. 10.1007/s000180050270", "ArticleIdList": ["10.1007/s000180050270", "10065152"]}, {"Citation": "Walters Haygood C. L., Arend R. C., Straughn J. M., Buchsbaum D. J. (2014). Ovarian Cancer Stem Cells: Can Targeted Therapy lead to Improved Progression-free Survival? World J. Stem Cell 6 (4), 441\u2013447. 10.4252/wjsc.v6.i4.441", "ArticleIdList": ["10.4252/wjsc.v6.i4.441", "PMC4172672", "25258665"]}, {"Citation": "Wang L., Su W., Liu Z., Zhou M., Chen S., Chen Y., et al. (2012). CD44 Antibody-Targeted Liposomal Nanoparticles for Molecular Imaging and Therapy of Hepatocellular Carcinoma. Biomaterials 33 (20), 5107\u20135114. 10.1016/j.biomaterials.2012.03.067", "ArticleIdList": ["10.1016/j.biomaterials.2012.03.067", "22494888"]}, {"Citation": "Wang Q., Peng H., Qi X., Wu M., Zhao X. (2020). Targeted Therapies in Gynecological Cancers: A Comprehensive Review of Clinical Evidence. Signal. Transduct Target. Ther. 5 (1), 1\u201334. 10.1038/s41392-020-0199-6", "ArticleIdList": ["10.1038/s41392-020-0199-6", "PMC7391668", "32728057"]}, {"Citation": "Wiegand K. C., Hennessy B. T., Leung S., Wang Y., Ju Z., McGahren M., et al. (2014). A Functional Proteogenomic Analysis of Endometrioid and clear Cell Carcinomas Using Reverse Phase Protein Array and Mutation Analysis: Protein Expression Is Histotype-specific and Loss of ARID1A/BAF250a Is Associated with AKT Phosphorylation. BMC cancer 14 (1), 120. 10.1186/1471-2407-14-120", "ArticleIdList": ["10.1186/1471-2407-14-120", "PMC3941949", "24559118"]}, {"Citation": "Wright J. D., Barrena Medel N. I., Sehouli J., Fujiwara K., Herzog T. J. (2012). Contemporary Management of Endometrial Cancer. Lancet 379 (9823), 1352\u20131360. 10.1016/S0140-6736(12)60442-5", "ArticleIdList": ["10.1016/S0140-6736(12)60442-5", "22444602"]}, {"Citation": "Yang H., Li Y., Li T., Xu M., Chen Y., Wu C., et al. (2014). Multifunctional Core/shell Nanoparticles Cross-Linked Polyetherimide-Folic Acid as Efficient Notch-1 siRNA Carrier for Targeted Killing of Breast Cancer. Sci. Rep. 4, 7072. 10.1038/srep07072", "ArticleIdList": ["10.1038/srep07072", "PMC4233336", "25400232"]}, {"Citation": "Yeramian A., Moreno-Bueno G., Dolcet X., Catasus L., Abal M., Colas E., et al. (2013). Endometrial Carcinoma: Molecular Alterations Involved in Tumor Development and Progression. Oncogene 32 (4), 403\u2013413. 10.1038/onc.2012.76", "ArticleIdList": ["10.1038/onc.2012.76", "22430211"]}, {"Citation": "Zhan Q., Wang C., Ngai S. (2013). Ovarian Cancer Stem Cells: a New Target for Cancer Therapy. Biomed. Res. Int. 2013, 916819. 10.1155/2013/916819", "ArticleIdList": ["10.1155/2013/916819", "PMC3581273", "23509802"]}, {"Citation": "Zhang Y., Ma B., Fan Q. (2010). Mechanisms of Breast Cancer Bone Metastasis. Cancer Lett. 292 (1), 1\u20137. 10.1016/j.canlet.2009.11.003", "ArticleIdList": ["10.1016/j.canlet.2009.11.003", "20006425"]}, {"Citation": "Zhu H., Luo H., Zhang W., Shen Z., Hu X., Zhu X. (2016). Molecular Mechanisms of Cisplatin Resistance in Cervical Cancer. Drug Des. Devel Ther. 10, 1885\u20131895. 10.2147/DDDT.S106412", "ArticleIdList": ["10.2147/DDDT.S106412", "PMC4907638", "27354763"]}, {"Citation": "Zuber E., Schweitzer D., Allen D., Parte S., Kakar S. S. (2020). Stem Cells in Ovarian Cancer and Potential Therapies. Proc. Stem Cell Res Oncog 8, e1001.", "ArticleIdList": ["PMC7413600", "32776013"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "27"}, {"Year": "2022", "Month": "1", "Day": "19"}, {"Year": "2022", "Month": "3", "Day": "7", "Hour": "6", "Minute": "2"}, {"Year": "2022", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["35250573", "PMC8888850", "10.3389/fphar.2022.823572", "823572"]}}], "PubmedBookArticle": []}